| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |